상세 보기
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer
- Kim, Nalee;
- Kim, Ji-Yeon;
- Park, Won;
- Cho, Won Kyung;
- Kim, Tae Gyu;
- ... Ahn, Jin Seok;
- ... Lee, Jeong Eon;
- ... Nam, Seok Jin;
- ... Kim, Seok Won;
- ... Yu, Jonghan;
- ... Chae, Byung Joo;
- ... Lee, Sei Kyung;
- ... Ryu, Jai -Min;
- ... Park, Yeon Hee;
- ... Kim, Haeyoung;
- 외 1명
WEB OF SCIENCE
1SCOPUS
1초록
Aim: The role of regional nodal irradiation (RNI) after preoperative systemic treatment (PST) with targeted therapy for HER2-positive breast cancer remains uncertain. This study aimed to investigate the impact of RNI on locoregional recurrence (LRR) and disease-free survival (DFS) outcomes after docetaxel/carboplatin/trastuzu-mab/pertuzumab (TCHP) for PST.Methods: We retrospectively analyzed 255 patients who were treated with six cycles of TCHP between 2016 and 2019. The patients were divided into four groups based on clinical nodal involvement: group A, with no nodal disease; group B, with axillary lymph node (AXL) level I; group C, with AXL level I with II/III; and group D, with supraclavicular or internal mammary nodes.Results: The RNI group had more advanced nodal disease (C/D) than the no RNI group (56.9 % vs. 6.8 %). With a median follow-up of 51.3 months, there were two (0.8 %), three (1.2 %), and 15 (5.9 %) local, regional, and distant metastases, respectively. LRR did not differ significantly according to the RNI (2.6 % vs. 1.0 %, p = 0.651). Group D had the most frequent distant metastases (17.5 %; p = 0.005). The 4-year DFS rate was 92.7 %, and DFS did not improve significantly after RNI (p = 0.074). When stratified by clinical nodal groups and pathological axillary response, RNI had no effect on LRR/DFS outcomes.Conclusion: With a rare incidence of LRR, RNI did not significantly affect LRR or DFS in patients with HER2-positive breast cancer after with PST-TCHP. However, intensive systemic treatment is required for advanced diseases (C/D). Selective de-intensified RNI and intensified systemic treatment should be investigated in future studies.
키워드
- 제목
- Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer
- 저자
- Kim, Nalee; Kim, Ji-Yeon; Park, Won; Cho, Won Kyung; Kim, Tae Gyu; Im, Young-Hyuck; Ahn, Jin Seok; Lee, Jeong Eon; Nam, Seok Jin; Kim, Seok Won; Yu, Jonghan; Chae, Byung Joo; Lee, Sei Kyung; Ryu, Jai -Min; Park, Yeon Hee; Kim, Haeyoung
- 발행일
- 2023-12
- 유형
- Article
- 저널명
- Breast
- 권
- 72
- 언어
- ENG
- 출판사
- Churchill Livingstone
- 발행국가
- 영국
- ISSN
- E 1532-3080
P 0960-9776